KORU Medical Systems, Inc.

KRMD Healthcare Medical Instruments & Supplies

KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

3.00 0.03 −0.99%
Market cap
$139.9M
P/E
0.0×
Fwd P/E
−89.3×
Dividend yield
—
F-score
5/9
Altman Z
14.46
Beneish M
−2.90
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Feb '17
Piotroski F-Score
5 5 5 2 2 2 4 7 — —
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 366.85 77.46 44.35 0.00
Altman Z-Score
14.46 9.64 7.62 8.91 17.59 41.91 60.54 27.26 20.85 8.88
P/S ratio
6.52 5.24 3.81 5.73 5.67 10.44 10.93 3.63 3.02 1.31
Altman Z″-Score (non-manufacturers)
(0.06) (0.54) 1.18 4.08 11.95 15.74 10.36 12.64 11.57 9.41
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 2,244.86 62.62 58.94 0.00
Beneish M-Score
(2.90) (3.33) (4.17) (1.97) (1.50) (2.83) (1.28) (2.77) (2.33) —
P/Operating CF
245.11 187.68 98.95 119.53 (185.69) (147.47) 307.83 496.15 99.73 (40.76)
P/B ratio
15.74 10.49 5.33 5.10 3.65 6.98 22.54 7.02 5.24 2.43
Price to Tangible BV
16.40 10.96 5.54 5.23 3.73 7.15 24.28 7.55 5.59 2.60
EV/Sales
6.31 4.96 3.41 5.12 4.59 9.31 10.68 3.32 2.70 1.02
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 267.15 39.12 24.06 0.00
EV/Operating CF
561.32 (522.25) (19.90) (26.41) (24.97) (302.97) 771.53 38.96 39.93 (23.14)
EV/FCF
(532.53) (101.02) (17.06) (17.39) (23.02) (126.56) 2,192.84 57.39 52.72 (12.27)
Quick Ratio
1.88 2.16 3.49 3.15 6.19 8.15 3.78 4.22 3.85 3.78
Current Ratio
2.44 2.66 4.55 4.28 7.79 10.24 4.94 5.70 5.00 4.88
Net Debt/EBITDA
4.07 1.69 1.19 1.67 3.86 34.27 (6.34) (3.57) (2.84) 8.77
Debt/Assets
0.28% 0.74% 1.11% 0.93% 0.00% 0.24% 0.02% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.01 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
1.48 1.21 0.81 0.67 0.58 0.90 1.90 1.75 1.53 1.48
Operating CF/Net income
(0.18) 0.05 0.36 0.62 0.95 0.61 0.57 1.63 0.99 0.62
Capex/Depreciation
(1.17) (1.50) (0.94) (4.77) (0.79) (2.25) (0.61) (1.54) (0.85) (1.26)
Interest Coverage
— — — (74.04) (536.60) (29.59) 7.26 41.44 426.38 (387.47)
ROE
(15.58%) (32.64%) (53.18%) (25.54%) (12.56%) (5.12%) 5.59% 10.95% 12.62% (7.76%)
ROA
(9.52%) (21.79%) (38.82%) (20.71%) (11.24%) (4.51%) 4.62% 9.19% 10.37% (6.46%)
ROIC
(22.51%) (54.19%) (69.86%) (47.08%) (39.35%) (8.78%) 6.82% 19.65% 22.52% (14.84%)
Return on Tangible Assets
(16.22%) (37.40%) (69.97%) (32.40%) (13.57%) (3.46%) 5.59% 10.96% 12.60% (8.46%)
Average Days of Receivables
57.95 65.07 52.14 59.29 66.99 38.85 50.97 29.99 51.04 49.72
Research and Development Expense of Revenue
10.67% 15.63% 20.14% 17.77% 10.53% 5.36% 3.20% 1.39% 0.38% 1.93%
Selling, General and Administrative Expense of Revenue
56.84% 64.29% 71.41% 73.87% 76.04% 49.75% 42.19% 47.23% 49.53% 63.18%
Intangible Assets out of Total Assets
0.02 0.03 0.03 0.02 0.02 0.02 0.06 0.06 0.05 0.05
Share Based Compensation of Revenue
6.60% 7.80% 9.71% 11.04% 11.53% 6.70% 5.20% 2.11% 0.81% 1.67%
Graham Net Nets
0.03 0.05 0.11 0.12 0.24 0.13 0.04 0.12 0.16 0.33
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.34 0.34 0.33 0.00
Earnings Yield
(1.11%) (3.12%) (12.18%) (5.63%) (3.33%) (0.57%) 0.27% 1.29% 2.25% (4.07%)
Free Cash Flow Yield
(0.18%) (0.94%) (5.26%) (5.14%) (3.52%) (0.70%) 0.04% 1.60% 1.70% (6.36%)
Revenue per Share
0.89 0.73 0.63 0.62 0.53 0.58 0.60 0.46 0.35 0.33
Operating CF per Share
0.01 (0.01) (0.11) (0.12) (0.10) (0.02) 0.01 0.04 0.02 (0.01)
Capex per Share
(0.02) (0.03) (0.02) (0.06) (0.01) (0.02) (0.01) (0.01) (0.01) (0.01)
Free Cash Flow per Share
(0.01) (0.04) (0.13) (0.18) (0.11) (0.04) 0.00 0.03 0.02 (0.02)
Cash per Share
0.19 0.21 0.25 0.39 0.57 0.65 0.15 0.14 0.11 0.09
Shareholders Equity per Share
0.37 0.37 0.45 0.70 0.82 0.86 0.29 0.24 0.20 0.18
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.37 0.37 0.45 0.70 0.82 0.86 0.29 0.24 0.20 0.18
Free Cash Flow
(0.49) (1.65) (5.71) (8.21) (4.69) (1.78) 0.11 1.00 0.68 (0.75)
Working Capital
11.79 11.93 15.80 22.84 32.53 33.86 9.48 7.45 6.34 5.39
Capital Expenditures
(0.95) (1.33) (0.81) (2.80) (0.37) (1.04) (0.21) (0.48) (0.22) (0.42)
Net Current Asset Value
8.84 8.73 12.15 18.80 32.53 33.76 9.24 7.45 6.32 5.29
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 422.25 49.51 29.06 0.00
Capex to Sales
0.02 0.04 0.03 0.10 0.02 0.04 0.01 0.03 0.02 0.03
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 432.26 54.02 32.49 0.00
Other line items
Depreciation/Fixed assets
0.18 0.21 0.23 0.15 0.42 0.39 0.56 0.36 0.31 0.35
Cash ROIC
(1.87%) (6.21%) (17.75%) (16.70%) (7.58%) (2.80%) 0.66% 7.07% 5.72% (7.28%)
Accounts Receivable Turnover
6.57 6.68 6.63 6.31 6.82 8.33 9.94 10.56 7.53 8.13
Accounts Payable Turnover
7.93 9.38 7.01 6.92 10.50 15.43 16.19 14.41 8.44 8.75
Inventory Turnover
4.79 3.92 2.39 2.00 1.50 2.00 3.70 3.48 3.44 3.95
Average Days of Payables
53.32 48.91 30.14 69.69 46.09 24.68 25.16 25.30 32.05 59.68
Days of Inventory on Hand
86.48 83.10 107.60 186.62 229.29 269.78 104.93 117.36 116.99 104.59
Average Receivables
6.26 5.04 4.30 4.42 3.44 2.90 2.33 1.64 1.77 1.51
Average Payables
1.96 1.31 1.68 1.81 0.93 0.60 0.51 0.45 0.61 0.54
Average Inventory
3.24 3.14 4.94 6.26 6.47 4.61 2.25 1.88 1.51 1.20
Average Assets
27.71 27.84 35.40 41.81 40.61 26.90 12.21 9.91 8.73 8.28
Average Common Equity
16.93 18.58 25.84 33.91 36.33 23.70 10.10 8.32 7.17 6.90

Fold the line items

Columns are period end dates